Package Insert: Information for the User
Ezetimiba/Atorvastatina Olpha 10 mg/10 mg Film-Coated Tablets
Ezetimiba/Atorvastatina Olpha 10 mg/20 mg Film-Coated Tablets
Ezetimiba/Atorvastatina Olpha 10 mg/40 mg Film-Coated Tablets
Ezetimiba/Atorvastatina Olpha 10 mg/80 mg Film-Coated Tablets
Read this package insert carefully before starting to take this medicine, as it contains important information for you.
Ezetimibe/Atorvastatin Olpha is a medication that decreases high levels of cholesterol. Ezetimibe/Atorvastatin Olpha contains ezetimibe and atorvastatin.
Ezetimibe/atorvastatin is used in adults to decrease total cholesterol, "bad" cholesterol (low-density lipoprotein, LDL) and certain fatty substances called triglycerides that circulate in the blood. Additionally, ezetimibe/atorvastatin increases concentrations of "good" cholesterol (high-density lipoprotein, HDL).
Ezetimibe/atorvastatin acts by reducing cholesterol in two ways. It reduces the cholesterol absorbed in the digestive tract, as well as the cholesterol that your body produces on its own.
Cholesterol is one of the fatty substances that are found in the circulatory system. Your total cholesterol is composed mainly of LDL and HDL.
LDL cholesterol is often referred to as "bad" cholesterol because it can accumulate in the walls of your arteries, forming plaques. Over time, this accumulation of plaque can cause a narrowing of the arteries. This narrowing can make the blood flow to vital organs such as the heart and brain slower or interrupted. This interruption of blood flow can trigger a myocardial infarction or a stroke.
HDL cholesterol is often referred to as "good" cholesterol because it helps to prevent the accumulation of bad cholesterol in the arteries and protects them from cardiovascular diseases.
Triglycerides are another type of fat present in your blood that can increase the risk of cardiovascular disease.
Ezetimibe/atorvastatin is used in patients who cannot control their cholesterol levels solely with diet. While taking this medication, you should follow a cholesterol-reducing diet.
Ezetimibe/atorvastatin is used, along with a cholesterol-reducing diet, if you have:
Ezetimibe/atorvastatin does not help you lose weight.
Warnings and Precautions
Consult your doctor or pharmacist before starting to take ezetimibe/atorvastatin.
Contact your doctor as soon as possible if you experience unexplained muscle pain, sensitivity, or muscle weakness while taking ezetimibe/atorvastatin.This is because, in rare cases, muscle problems can be severe, including muscle rupture causing kidney damage. It is known that atorvastatin causes muscle problems, and muscle problems have also been reported with ezetimibe.
Also, inform your doctor or pharmacist if you experience constant muscle weakness. Additional tests and medications may be necessary to diagnose and treat this problem.
Consult your doctor or pharmacist before starting to take ezetimibe/atorvastatin:
If you are in any of the above circumstances (or are unsure), consult your doctor before starting to take ezetimibe/atorvastatin, as your doctor will need to perform a blood test before starting your treatment with ezetimibe/atorvastatin, and possibly during it, to predict the risk of experiencing adverse muscle effects. It is known that the risk of experiencing adverse muscle effects, e.g., rhabdomyolysis, increases when certain medications are taken simultaneously (see section 2 “Other Medications and Ezetimibe/Atorvastatin Olpha”).
While you are taking this medication, your doctor will monitor if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high blood sugar and lipid levels, obesity, and high blood pressure.
Inform your doctor about all your medical conditions, including allergies.
You should avoid using ezetimibe/atorvastatin and fibrates (certain medications to lower cholesterol) together, as the combined use of ezetimibe/atorvastatin and fibrates has not been studied.
Children
Ezetimibe/atorvastatin is not recommended for children and adolescents.
Other Medications and Ezetimibe/Atorvastatin Olpha
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
There are some medications that can modify the effect of ezetimibe/atorvastatin or whose effects may be affected by ezetimibe/atorvastatin (see section 3). This type of interaction could reduce the effectiveness of one or both medications. On the other hand, it could also increase the risk or severity of adverse effects, including a severe condition in which muscle is destroyed, known as “rhabdomyolysis”, which is described in section 4:
some medications used to treat hepatitis C, e.g., telaprevir, boceprevir, and the combination of elbasvir/grazoprevir, ledipasvir/sofosbuvir,
** If you need to take fusidic acid orally to treat a bacterial infection, you will need to temporarily stop taking this medication. Your doctor will tell you when you can restart your treatment with ezetimibe/atorvastatin. The use of ezetimibe/atorvastatin with fusidic acid rarely can cause muscle weakness, sensitivity, or pain (rhabdomyolysis). For more information on rhabdomyolysis, see section 4.
Taking Ezetimibe/Atorvastatin Olpha with Food and Alcohol
See section 3 for instructions on how to take ezetimibe/atorvastatin. Please note the following:
Orange Juice
Do not take more than one or two small glasses of orange juice per day, as large amounts of orange juice can alter the effects of ezetimibe/atorvastatin.
Alcohol
Avoid excessive alcohol consumption while taking this medication. For more details, see section 2 “Warnings and Precautions”.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor before using this medication. Do not take ezetimibe/atorvastatin if you may become pregnant, unless you use reliable contraceptive methods. If you become pregnant while taking ezetimibe/atorvastatin, stop taking it immediately and inform your doctor.
Do not takeezetimibe/atorvastatinif you are breastfeeding.
The safety of ezetimibe/atorvastatin during pregnancy and breastfeeding has not been proven.
Consult your doctor or pharmacist before taking this medication.
Driving and Using Machines
Ezetimibe/atorvastatin is not expected to interfere with your ability to drive or use machines. However, some people may experience dizziness after taking ezetimibe/atorvastatin.
Ezetimibe/Atorvastatin Olpha contains lactose
The tablets of Ezetimibe/Atorvastatin contain a sugar called lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with your doctor before taking this medication.
Ezetimibe/Atorvastatin Olpha contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; that is, it is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor. Your doctor will determine the appropriate dose per tablet for you, depending on your current treatment and personal risk situation. In case of doubt, consult your doctor or pharmacist again.
What quantity to take
The recommended dose is one tablet of ezetimiba/atorvastatina once a day taken orally.
Administration form
Take Ezetimiba/Atorvastatina Olpha at any time of the day. You can take it with or without food.
If your doctor has prescribed ezetimiba/atorvastatina along with cholestyramine or any other bile acid sequestrant (medications that reduce cholesterol levels), you must take ezetimiba/atorvastatina at least 2 hours before or 4 hours after taking the bile acid sequestrant.
If you take more Ezetimiba/Atorvastatina Olpha than you should
Consult with your doctor or pharmacist.
If you forgot to take Ezetimiba/Atorvastatina Olpha
Do not take a double dose to compensate for the missed doses. The next day, take your usual amount of ezetimiba/atorvastatina at the usual time.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following serious side effects or symptoms, stop taking your tablets and immediately inform your doctor, or go to the nearest hospital emergency department.
Consult your doctor as soon as possible if you experience problems associated with the unexpected or unusual appearance of bleeding or bruising, as this may be indicative of liver disease.
The following side effects were frequently reported (may affect up to 1 in 10 patients):
The following side effects were infrequently reported (may affect up to 1 in 100 patients):
In addition, the following side effects have been reported in people taking ezetimibe/atorvastatin, ezetimibe, or atorvastatin tablets alone:
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision, eyelid drooping, difficulty swallowing, or difficulty breathing.
Possible side effects reported with some statins
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging or on the container after “CAD”. The expiration date is the last day of the month indicated.
This medication does not require any special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Ezetimiba/Atorvastatina Olpha
The active principles are ezetimiba and atorvastatina. Each film-coated tablet contains 10 mg of ezetimiba and 10 mg, 20 mg, 40 mg or 80 mg of atorvastatina (as atorvastatina calcium trihydrate).
The other components are: calcium carbonate; anhydrous colloidal silica; sodium croscarmellose; hydroxypropylcellulose; lactose monohydrate; povidone, magnesium stearate; microcrystalline cellulose; polisorbate 80; sodium laurylsulfate (E487).
The coating of the tablet contains: hypromelose, lactose monohydrate, titanium dioxide (E171), macrogol, talc.
Appearance of the product and content of the package
Film-coated, biconvex, capsule-shaped tablets, white to off-white in color.
Ezetimiba/Atorvastatina Olpha 10 mg/10 mg tablets EFG: with “1T” engraved on one face.
Ezetimiba/Atorvastatina Olpha 10 mg/20 mg tablets EFG: with “2T” engraved on one face.
Ezetimiba/Atorvastatina Olpha 10 mg/40 mg tablets EFG: with “4T” engraved on one face.
Ezetimiba/Atorvastatina Olpha 10 mg/80 mg tablets EFG: with “8T” engraved on one face.
Pack sizes:
Pack sizes of 10, 30, 90 and 100 film-coated tablets in aluminium/aluminium blisters.
Only some pack sizes may be marketed.
Marketing Authorization Holder
Olpha AS,
Rupnicu iela 5,
Olaine, Olaines novads, LV-2114,
Latvia
Responsible for manufacturing
Delorbis Pharmaceuticals LTD,
17 Athinon street,
Ergates Industrial Area,
2643Ergates Lefkosia,
Cyprus
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
Slovakia: | Ezetimibe/Atorvastatin Olpha 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, 10 mg/80 mg filmom obalené tablety |
Spain: | Ezetimiba/Atorvastatina Olpha 10 mg/10 mg film-coated tablets EFG Ezetimiba/Atorvastatina Olpha 10 mg/20 mg film-coated tablets EFG Ezetimiba/Atorvastatina Olpha 10 mg/40 mg film-coated tablets EFG Ezetimiba/Atorvastatina Olpha 10 mg/80 mg film-coated tablets EFG |
Estonia: | Ezetimibe/Atorvastatin Olpha |
France: | Ezetimibe/Atorvastatine Olpha 10 mg/10 mg film-coated tablet Ezetimibe/Atorvastatine Olpha 10 mg/20 mg film-coated tablet Ezetimibe/Atorvastatine Olpha 10 mg/40 mg film-coated tablet Ezetimibe/Atorvastatine Olpha 10 mg/80 mg film-coated tablet |
Latvia: | Ezetimibe/Atorvastatin Olpha 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, 10 mg/80 mg apvalkotas tabletes |
Lithuania: | Ezetimibe/Atorvastatin Olpha 10 mg/10 mg coated tablets Ezetimibe/Atorvastatin Olpha 10 mg/20 mg coated tablets Ezetimibe/Atorvastatin Olpha 10 mg/40 mg coated tablets Ezetimibe/Atorvastatin Olpha 10 mg/80 mg coated tablets |
Netherlands: | Ezetimibe/Atorvastatine Olpha 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, 10 mg/80 mg filmomhulde tabletten |
Last review date of this leaflet: November 2024
Detailed and updated information on this medicinal product is available on the website of theSpanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.